- Home
- LTRX vs ALEC Comparison
LTRX vs ALEC Comparison
Compare LTRX & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTRX | ALEC |
|---|---|---|
| Founded | 1989 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.4M | 262.7M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LTRX | ALEC |
|---|---|---|
| Price | $6.41 | $2.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $6.50 | $4.83 |
| AVG Volume (30 Days) | 474.8K | ★ 609.6K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $122,923,000.00 | $21,045,000.00 |
| Revenue This Year | $1.12 | $18.36 |
| Revenue Next Year | $15.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.04 | $0.98 |
| 52 Week High | $8.24 | $3.40 |
Technical Indicators
Market Signals| Indicator | LTRX | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 62.17 | 53.76 |
| Support Level | $6.05 | $1.89 |
| Resistance Level | $6.73 | $2.57 |
| Average True Range (ATR) | 0.28 | 0.17 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 77.37 | 52.94 |
Price Performance
Historical ComparisonAbout LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.